Despite the growing ubiquity of GLP-1 (glucagon-like peptide-1) medication use, there is still quite a bit of confusion, stigma, and misinformation surrounding injections like Ozempic.
Many people are unsure about how these medications work, their safety, and who should use them. This lack of clear information often leads to misunderstandings and unwarranted fear.
Additionally, there is a significant lack of access for many patients who could benefit from these medications. Barriers such as cost, insurance coverage, and limited availability make it difficult for some individuals to obtain the treatment they need.
Fitish founder Jenna…
[Continue reading]
https://fashionista.com/2025/10/fitish-wellness-brand-glp1-weight-loss-business